← Leaderboards
David C Montrose
State University New York Stony Brook
$688,434
Attributed
$688,434
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $229.5K · FY2019–21$250K$187.5K$125K$62.5K$0
'19
'20
'21
Funding mix
By agency
NIH$688,434 · 1
By mechanism
K22$688,434 · 1
Top collaborators
No co-investigators on record.
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Jennie L Williams$3,944,004
- Evguenia Alexandrova$473,229
- Jerome Z Liang$8,132,671
- Nengtai Ouyang$152,467
Others in their field
Other Emerging Leaders on “Anticancer Research”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$238,320,768
- Leonard Freedman · Leidos Biomedical Research, Inc.$161,112,755
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$39,889,328
- Dwayne Forquer · Leidos Biomedical Research, Inc.$29,410,041
- Leonard Freedmand · Leidos Biomedical Research, Inc.$22,652,885
Research focus
Anticancer ResearchApc GeneApcmin/+ MiceAwardAzoxymethaneCancer CellCancer EtiologyCancer PreventionCancer TherapyCancer TypeCarbonCareerCelecoxibCell Culture SystemCell PhysiologyCell ProliferationCellsCessation Of LifeChemopreventive AgentClinically RelevantColon Cancer PreventionColon CarcinomaColon GrowthAnabolism
Grant awards (3)
Reducing serine biosynthesis and utilization as a novel approach for colon cancer prevention$229,478
K22 · FY2021 · CA · contact PI
Reducing serine biosynthesis and utilization as a novel approach for colon cancer prevention$229,478
K22 · FY2020 · CA · contact PI
Reducing serine biosynthesis and utilization as a novel approach for colon cancer prevention$229,478
K22 · FY2019 · CA · contact PI